LabPulse.com staff writersFinancingKarius raises $100M in series C fundingDiagnostics firm Karius has secured $100 million in series C funding.May 6, 2024CollaborationNovo Nordisk Foundation, Wellcome, Gates Foundation to partner on global health challengesThe Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation have announced a collaboration to support scientific research and development for accessible solutions to global health challenges.May 6, 2024Trends and FinanceCue Health to cut 230 jobs in restructuring planIn a filing with the U.S. Securities and Exchange Commission, Cue Health said it intends to cut 230 jobs, 49% of its workforce, as part of a cost-reduction plan the firm is implementing.May 3, 2024CollaborationAstellas and Poseida to collaborate on oncology cell therapiesPoseida Therapeutics and Astellas, under its Xyphos Biosciences subsidiary, have initiated a research collaboration and licensing agreement to develop allogeneic cell therapy programs by combining their innovative cell therapy platforms and technologies.May 2, 2024FDA ClearanceLeica Biosystems, Sectra receive FDA 510(k) clearance for digital pathology systemLeica Biosystems has received 510(k) clearance from the U.S Food and Drug Administration (FDA) for its Aperio GT 450 DX digital pathology system, in conjunction with Sectra's digital pathology software.May 2, 2024Research AllianceGSK, Genomics PLC collaborate on polygenic risk score use for clinical trialsGenomics PLC and biopharmaceutical firm GSK have established a collaboration aimed at assessing the potential for using polygenic risk scores in clinical trials.May 1, 2024Pathology and AIQuest Diagnostics to add digital pathology lab, AI pathology center in TennesseeQuest Diagnostics said it will acquire PathAI Diagnostics in Memphis, TN, the business of PathAI that provides anatomic and digital pathology laboratory services, to accelerate the adoption of digital and AI pathology.May 1, 2024FinancingVariantyx raises $36M in fundingPrecision molecular diagnostics firm Variantyx has raised $36 million in a recent funding round, bringing the total funding that Variantyx has raised to more than $125 million.April 30, 2024Mergers & AcquisitionsLabcorp buys Invitae portfolio for $239MLabcorp was the winning bidder in the court-supervised auction of Invitae's assets, obtaining substantially all of the San Francisco-based company's business for $239 million in cash consideration with other noncash consideration.April 26, 2024Financial ResultsBristol Myers Squibb to reduce workforce in restructuring planAs part of a restructuring plan intended to cut $1.5 billion in costs, Bristol Myers Squibb plans to cut about 6% of its workforce, according to the firm.April 25, 2024Page 1 of 341Next PageTop StoriesDiagnostic TechnologiesFDA said no to proficiency testing for LDT qualityInferior tests can pass through proficiency testing, among ways PT falls short for test safety and effectiveness for intended purposes.Trends and FinanceCue Health to cut 230 jobs in restructuring planFDA ClearanceLeica Biosystems, Sectra receive FDA 510(k) clearance for digital pathology systemPolicy and RegulationFDA releases LDT final ruleSponsor ContentVisit our Molecular Diagnostics Community
